Saakshi Medtech & Panels Ltd
Saakshi Medtech & Panels Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #57 of 58 in Electrical Equipment
See the sector's top 10 — free with your mobile number.
What the Q2 FY26 call signalled
2 of 5 strong
The short version
The company targets revenue of around Rs. The company expects approximately 15% revenue growth in H2 FY'26 compared to H1 FY'26. - For FY'27 and beyond, growth drivers include aerospace and radiator businesses expected to significantly boost revenues. - Aerospace segment is anticipated to contribute around 20% of revenue within the next couple of years with better-than-20% EBITDA margins. - Radiator business margins are expected around 20% once scaled. - EBITDA margins improved to around 18.7% in H1 FY'26 and are expected to sustain at similar levels in the near term. - Operating leverage and new high-margin segments (aerospace, radiators) are key margin expansion drivers. - The potential revenue target from current assets gross block (~Rs.
From Saakshi Medtech & Panels Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- The company targets revenue of around Rs. 140 crores for the current financial year FY'26, with H2 expected to outperform H1 by roughly 15%.
- Significant growth drivers include aerospace and EV business segments, showing strong momentum and new opportunities.
- The aerospace segment has seen nearly a 7-fold growth in H1 FY'26 compared to H1 FY'25 and is expected to contribute up to 20% of revenue within a couple of years.
- Radiator business is set to contribute significantly starting FY'27, supported by a new facility and early customer interest.
- Order book visibility is typically quarterly; currently, about Rs. 50 crores of orders for the ongoing quarter, with defense orders being a small portion (~5%).
2 more points from Saakshi Medtech & Panels Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Saakshi Medtech & Panels Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current CAPEX includes ongoing infrastructure build-out with Rs. 15 crores invested and Rs. 9.4 crores in CWIP (Page 5).
- New term loans have been taken for constructing the first floor of the newly acquired facility (Page 10).
- Final CAPEX of around Rs. 5 crores is expected for completing the new facility, which consolidates three previous locations (Page 10).
- No significant new CAPEX is planned beyond this as future expansion and growth will be funded mainly through cash flows generated by the business, without additional debt (Page 10).
2 more points from Saakshi Medtech & Panels Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Electrical Equipment
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Saakshi Medtech & Panels Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current quarter order book stands at approximately Rs. 50 crores.
- Defense portion forms about 5% of the current order book.
- The Mahindra EV Panel's 5-year order remains intact with ongoing execution; Rs. 10 crores executed from Feb '24 to Sept '25, with around Rs. 230 crores pending over the next 4 years.
- The company typically has rolling quarterly visibility on orders rather than a long-term order book.
2 more points from Saakshi Medtech & Panels Ltd's call on order book
Create a free account to keep reading this call
Continue your research
What Saakshi Medtech & Panels Ltd's management said in earlier quarters
Others in Electrical Equipment this season
- Inox Wind Ltd (Q2 FY26)
200 crore. Key concall takeaways from Inox Wind Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Prostarm Info Systems Ltd (Q2 FY26)
Q2-FY26 Revenue from Operations: INR 659 Mn, down 33.1% YoY (Q2-FY25: INR 985 Mn) . Key investor presentation takeaways from Prostarm Info Systems Ltd's Q2 FY26
- Power & Instrumentation (Gujarat) Ltd (Q2 FY26)
Net Sales: ₹70.27 Cr (up from ₹54.93 Cr in Q2 FY25) — approx. Key investor presentation takeaways from Power & Instrumentation (Gujarat) Ltd's Q2 FY26 investor
- Triveni Turbine Ltd (Q2 FY26)
The outstanding order book is at a record ₹22.2 billion, which is 24% higher year-over-year. Key concall takeaways from Triveni Turbine's Q2 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Electrical Equipment
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Saakshi Medtech & Panels Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Saakshi Medtech & Panels Ltd Q2 FY26 results?
The company targets revenue of around Rs. The company expects approximately 15% revenue growth in H2 FY'26 compared to H1 FY'26. - For FY'27 and beyond, growth drivers include aerospace and radiator businesses expected to significantly boost revenues. - Aerospace segment is anticipated to contribute around 20% of revenue within the next couple of years with better-than-20% EBITDA margins. - Radiator business margins are expected around 20% once scaled. - EBITDA margins improved to around 18.7% in H1 FY'26 and are expected to sustain at similar levels in the near term. - Operating leverage and new high-margin segments (aerospace, radiators) are key margin expansion drivers. - The potential revenue target from current assets gross block (~Rs.
What is Saakshi Medtech & Panels Ltd share price analysis?
Saakshi Medtech & Panels Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.4 with a market cap of ₹521 Cr. Investors should review the full earnings analysis for detailed insights.
Is Saakshi Medtech & Panels Ltd planning capital expenditure?
Current CAPEX includes ongoing infrastructure build-out with Rs.
Keep Saakshi Medtech & Panels Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
